NMR Experiment |
---|
Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
---|
1 | 2D 1H-15N TROSY HSQC | 1.2 mM [U-100% 13C; U-100% 15N; U-85% 2H] HIV-1 gp41 MPER-TMD-CT, 40 mM DMPC, 80 mM DHPC, 40 mM MES, 1 % sodium azide | 90% H2O/10% D2O | 0 M | 6.7 | 1 atm | 308 | Bruker AVANCE III 900 |
2 | 3D TROSY HNCO | 1.2 mM [U-100% 13C; U-100% 15N; U-85% 2H] HIV-1 gp41 MPER-TMD-CT, 40 mM DMPC, 80 mM DHPC, 40 mM MES, 1 % sodium azide | 90% H2O/10% D2O | 0 M | 6.7 | 1 atm | 308 | Bruker AVANCE III 900 |
3 | 3D TROSY HNCA | 1.2 mM [U-100% 13C; U-100% 15N; U-85% 2H] HIV-1 gp41 MPER-TMD-CT, 40 mM DMPC, 80 mM DHPC, 40 mM MES, 1 % sodium azide | 90% H2O/10% D2O | 0 M | 6.7 | 1 atm | 308 | Bruker AVANCE III 900 |
4 | 2D 1H-15N TROSY HSQC | 1 mM [ILV-100% 13C; U-100% 15N; U-85% 2H] HIV-1 gp41 MPER-TMD-CT, 40 mM DMPC, 80 mM DHPC, 40 mM MES, 1 % sodium azide | 90% H2O/10% D2O | 0 M | 6.7 | 1 atm | 308 | Bruker AVANCE III 900 |
5 | 2D 1H-13C HSQC | 1 mM [ILV-100% 13C; U-100% 15N; U-85% 2H] HIV-1 gp41 MPER-TMD-CT, 40 mM DMPC, 80 mM DHPC, 40 mM MES, 1 % sodium azide | 90% H2O/10% D2O | 0 M | 6.7 | 1 atm | 308 | Bruker AVANCE III 900 |
8 | 3D 15N-edited NOESY-TROSY-HSQC | 1 mM [ILV-100% 13C; U-100% 15N; U-85% 2H] HIV-1 gp41 MPER-TMD-CT, 40 mM DMPC, 80 mM DHPC, 40 mM MES, 1 % sodium azide | 90% H2O/10% D2O | 0 M | 6.7 | 1 atm | 308 | Bruker AVANCE III 900 |
7 | 3D 13C-edited NOESY | 1 mM [ILV-100% 13C; U-100% 15N; U-85% 2H] HIV-1 gp41 MPER-TMD-CT, 40 mM DMPC, 80 mM DHPC, 40 mM MES, 1 % sodium azide | 90% H2O/10% D2O | 0 M | 6.7 | 1 atm | 308 | Bruker AVANCE III 900 |
6 | 3D 15N-edited TROSY-NOESY-TROSY-HSQC | 1 mM [ILV-100% 13C; U-100% 15N; U-85% 2H] HIV-1 gp41 MPER-TMD-CT, 40 mM DMPC, 80 mM DHPC, 40 mM MES, 1 % sodium azide | 90% H2O/10% D2O | 0 M | 6.7 | 1 atm | 308 | Bruker AVANCE III 900 |